{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:56:46Z","timestamp":1776704206168,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Celiac disease (CD) is characterized by elevated serum titers of autoantibodies IgA anti-tissue transglutaminase 2 (TGA-IgA) and IgA anti-endomysial (EMA), with small bowel mucosa atrophy. We evaluated age differences between CD children exhibiting variable antibody titers at diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CD children diagnosed between January 2014 and June 2019, according to 2012 ESPGHAN guidelines were studied. All had EMA and TGA-IgA measurements, while a proportion of them underwent esophagogastroduodenoscopy (EGD). Patients were grouped based on serum TGA-IgA titers normalized to the upper limit of normal (ULN) and differences in median age (years) assessed by analysis of variance (ANOVA)\u00a0and creation of orthogonal contrasts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CD was diagnosed in 295 subjects (median age: 4.4 [IQR: 2.60\u20138.52]) with a biopsy sparing protocol (high titer:\u2009\u2265\u200910xULN) and in 204 by EGD biopsy. Of the latter, 142 (median age: 8.5 [IQR: 5.81\u201311.06]) and 62 (median age: 9.5 [IQR: 6.26\u201312.76]) had a low (&lt;\u20095xULN) and a moderate (\u2265\u20095\u2009&lt;\u200910xULN) TGA-IgA titer, respectively. Potential CD was diagnosed in 20 patients (median age: 3.6 [IQR: 2.47\u20136.91]). The median age was significantly lower in the no-biopsy group (ANOVA: F<jats:sub>(3, 516)<\/jats:sub>\u2009=\u200925.98, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001) than in low- and moderate titer groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), while there was no statistical difference between biopsy-sparing and potential CD groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CD patients with greatly elevated antibody titers (\u2265\u200910xULN) were diagnosed at an earlier age than those with lower titers. This may indicate that an increase in TGA-IgA is independent of age and suggests a polarization of autoimmunity in younger individuals with higher serum antibody levels.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-023-01435-6","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T21:24:05Z","timestamp":1679606645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of age in dynamics of autoantibodies in pediatric Celiac disease"],"prefix":"10.1186","volume":"49","author":[{"given":"Chiara Maria","family":"Trovato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Montuori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Leter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Laudadio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusy","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"issue":"7","key":"1435_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3109\/07853890.2010.514285","volume":"42","author":"C Catassi","year":"2010","unstructured":"Catassi C, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42(7):530\u20138.","journal-title":"Ann Med"},{"issue":"5","key":"1435_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/MPG.0000000000003047","volume":"72","author":"CM Trovato","year":"2021","unstructured":"Trovato CM, et al. Diagnostic Value of Persistently Low Positive TGA-IgA Titers in Symptomatic Children With Suspected Celiac Disease. J Pediatr Gastroenterol Nutr. 2021;72(5):712\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1435_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2036.2010.04543.x","volume":"33","author":"M Marine","year":"2011","unstructured":"Marine M, et al. The prevalence of coeliac disease is significantly higher in children compared with adults. Aliment Pharmacol Ther. 2011;33(4):477\u201386.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1435_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","volume":"62","author":"JF Ludvigsson","year":"2013","unstructured":"Ludvigsson JF, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43\u201352.","journal-title":"Gut"},{"issue":"5","key":"1435_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cgh.2007.01.003","volume":"5","author":"MR Donaldson","year":"2007","unstructured":"Donaldson MR, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5(5):567\u201373.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1435_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MCG.0000000000000105","volume":"49","author":"P Singh","year":"2015","unstructured":"Singh P, et al. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease. J Clin Gastroenterol. 2015;49(3):212\u20137.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"1435_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","volume":"54","author":"S Husby","year":"2012","unstructured":"Husby S, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136\u201360.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"1435_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","volume":"70","author":"S Husby","year":"2020","unstructured":"Husby S, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141\u201356.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1435_CR9","first-page":"278","volume":"12","author":"R Assandri","year":"2019","unstructured":"Assandri R, Montanelli A. Diagnosis of gluten-related enteropathy in a newborn: how and when? Gastroenterol Hepatol Bed Bench. 2019;12(4):278\u201386.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"1435_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.14309\/ajg.0000000000002192","volume":"118","author":"F Valitutti","year":"2023","unstructured":"Valitutti F, et al. Early Antibody Dynamics in a Prospective Cohort of Children At Risk of Celiac Disease. Am J Gastroenterol. 2023;118:574\u20137 published online ahead of print, 2023 Feb 9.","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"1435_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.clim.2003.08.010","volume":"109","author":"C Tiberti","year":"2003","unstructured":"Tiberti C, et al. Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependent. Clin Immunol. 2003;109(3):318\u201324.","journal-title":"Clin Immunol"},{"issue":"9","key":"1435_CR12","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1111\/j.1572-0241.2008.01977.x","volume":"103","author":"S Vivas","year":"2008","unstructured":"Vivas S, et al. Age-related clinical, serological, and histopathological features of celiac disease. Am J Gastroenterol. 2008;103(9):2360\u20135 quiz 2366.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1435_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/jcp.2004.023978","volume":"58","author":"GR Corazza","year":"2005","unstructured":"Corazza GR, Villanacci V. Coeliac disease. J Clin Pathol. 2005;58(6):573\u20134.","journal-title":"J Clin Pathol"},{"issue":"10","key":"1435_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","volume":"11","author":"G Oberhuber","year":"1999","unstructured":"Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11(10):1185\u201394.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"1435_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1023\/B:DDAS.0000026296.02308.00","volume":"49","author":"JA Abrams","year":"2004","unstructured":"Abrams JA, et al. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49(4):546\u201350.","journal-title":"Dig Dis Sci"},{"issue":"43","key":"1435_CR16","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"issue":"12","key":"1435_CR17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1136\/gut.2005.071514","volume":"55","author":"TT Salmi","year":"2006","unstructured":"Salmi TT, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006;55(12):1746\u201353.","journal-title":"Gut"},{"key":"1435_CR18","doi-asserted-by":"publisher","first-page":"108621","DOI":"10.1016\/j.clim.2020.108621","volume":"222","author":"Y Yao","year":"2021","unstructured":"Yao Y, et al. T cell receptor repertoire as a potential diagnostic marker for celiac disease. Clin Immunol. 2021;222:108621.","journal-title":"Clin Immunol"},{"issue":"3","key":"1435_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1053\/j.gastro.2019.10.006","volume":"158","author":"C Ciszewski","year":"2020","unstructured":"Ciszewski C, et al. Identification of a gammac Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21. Gastroenterology. 2020;158(3):625-637 e13.","journal-title":"Gastroenterology"},{"issue":"9","key":"1435_CR20","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.dld.2016.05.024","volume":"48","author":"U Volta","year":"2016","unstructured":"Volta U, et al. Seronegative celiac disease: Shedding light on an obscure clinical entity. Dig Liver Dis. 2016;48(9):1018\u201322.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"1435_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/JPEM.2002.15.1.47","volume":"15","author":"O Kordonouri","year":"2002","unstructured":"Kordonouri O, et al. Age-specific levels of diabetes-related GAD and IA-2 antibodies in healthy children and adults. J Pediatr Endocrinol Metab. 2002;15(1):47\u201352.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1435_CR22","doi-asserted-by":"publisher","first-page":"2630827","DOI":"10.1155\/2020\/2630827","volume":"2020","author":"G Ozen","year":"2020","unstructured":"Ozen G, et al. The association of autoimmune diseases with Type 1 Diabetes Mellitus in Children Depends Also by the Length of Partial Clinical Remission Phase (Honeymoon). Int J Endocrinol. 2020;2020:2630827.","journal-title":"Int J Endocrinol"},{"key":"1435_CR23","first-page":"251730","volume":"2012","author":"MJ Amador-Patarroyo","year":"2012","unstructured":"Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G. How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis. 2012;2012:251730.","journal-title":"Autoimmune Dis"},{"issue":"2","key":"1435_CR24","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.2337\/dc16-2095","volume":"40","author":"C Tiberti","year":"2017","unstructured":"Tiberti C, et al. Screening for Type 1 Diabetes-, Thyroid-, Gastric-, and Adrenal-Specific Humoral Autoimmunity in 529 Children and Adolescents With Celiac Disease at Diagnosis Identifies as Positive One in Every Nine Patients. Diabetes Care. 2017;40(2):e10\u20131.","journal-title":"Diabetes Care"},{"key":"1435_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fped.2019.00357","volume":"7","author":"A Popp","year":"2019","unstructured":"Popp A, Maki M. Changing Pattern of Childhood Celiac Disease Epidemiology: Contributing Factors. Front Pediatr. 2019;7:357.","journal-title":"Front Pediatr"},{"issue":"12","key":"1435_CR26","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nri2670","volume":"9","author":"B Jabri","year":"2009","unstructured":"Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol. 2009;9(12):858\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1435_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gie.2013.06.012","volume":"79","author":"F Valitutti","year":"2014","unstructured":"Valitutti F, et al. Mapping histologic patchiness of celiac disease by push enteroscopy. Gastrointest Endosc. 2014;79(1):95\u2013100.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"1435_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1053\/j.gastro.2019.04.004","volume":"157","author":"R Auricchio","year":"2019","unstructured":"Auricchio R, et al. Progression of celiac disease in children with antibodies against tissue transglutaminase and normal duodenal architecture. Gastroenterology. 2019;157(2):413-420 e3.","journal-title":"Gastroenterology"},{"key":"1435_CR29","doi-asserted-by":"publisher","first-page":"8974751","DOI":"10.1155\/2019\/8974751","volume":"2019","author":"CM Trovato","year":"2019","unstructured":"Trovato CM, et al. The challenge of treatment in potential celiac disease. Gastroenterol Res Pract. 2019;2019:8974751.","journal-title":"Gastroenterol Res Pract"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01435-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-023-01435-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01435-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T21:24:35Z","timestamp":1679606675000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-023-01435-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1186\/s13052-023-01435-6","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"22 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was defined in accordance with the Declaration of Helsinki and approved by the Ethical Committee of the University Hospital Umberto I in Rome. All participants gave their consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}